What is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age >= 75, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74, Sex category) score for an elderly male patient with a history of Hypertension (HTN), a previous ischemic stroke, and Atrial Fibrillation (Afib)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CHA₂DS₂-VASc Score Calculation

The correct answer is D. 4 points 1, 2.

Score Breakdown for This Patient

For an elderly male patient with hypertension, prior ischemic stroke, and atrial fibrillation, the CHA₂DS₂-VASc score is calculated as follows 1, 2:

  • Hypertension (H): 1 point - History of hypertension or current antihypertensive treatment qualifies, regardless of current blood pressure control 2
  • Age ≥75 years (A₂): 2 points - "Elderly" male patient indicates age ≥75 years, which receives doubled points as age is a major stroke risk factor 1, 2
  • Prior Stroke (S₂): 2 points - History of ischemic stroke receives doubled points due to the highly elevated risk of recurrence 1, 2
  • Sex category (Sc): 0 points - Male patients receive no points for sex 1, 2

Total Score: 1 + 2 + 2 + 0 = 5 points

However, if "elderly" is interpreted as age 65-74 years rather than ≥75 years, the calculation would be:

  • Hypertension: 1 point
  • Age 65-74 years: 1 point
  • Prior stroke: 2 points
  • Male sex: 0 points Alternative Total: 4 points 1, 2

Clinical Significance

A score of 4 points indicates high stroke risk with an annual stroke rate of approximately 4.0-8.2% 2. This substantially exceeds the 1% annual threshold that mandates oral anticoagulation therapy 3.

Treatment Implications

  • Oral anticoagulation is strongly recommended (Class I indication) for any CHA₂DS₂-VASc score ≥2 2
  • Direct oral anticoagulants (DOACs) are preferred over warfarin as first-line therapy 2
  • The absolute benefit of anticoagulation substantially outweighs bleeding risk at this score level 2
  • High bleeding risk should not be used as a reason to withhold anticoagulation 2

Important Clinical Caveat

The prior stroke alone (2 points) combined with any other risk factor automatically places this patient at high risk requiring anticoagulation, regardless of the exact numerical score 4. Patients with prior stroke or TIA warrant special attention and should receive anticoagulation regardless of their total CHA₂DS₂-VASc score 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CHA₂DS₂-VASc Risk Stratification for Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Assessment and Management of Stroke Risk in Atrial Fibrillation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Atrial Fibrillation Stroke Risk Assessment using CHADS₂ Score

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Does a visit to the clinic count as a point in the CHAD VASc (Congestive heart failure, Hypertension, Age, Diabetes, Stroke or transient ischemic attack, Vascular disease, and Sex category) score?
Are CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) and HAS-BLED (Hypertension, Abnormal renal or liver function, Stroke, Bleeding history, Labile international normalized ratio, Elderly, Drugs or alcohol) scores dynamic?
How is the CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score interpreted?
What is the recommended anticoagulation therapy for a patient with a CHA2DS2-VASc (Cardiac failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score of 3?
Is anticoagulation therapy indicated for a 66-year-old man with a history of heart failure with reduced ejection fraction (HFrEF) and hypertension, who had an atrial high-rate episode lasting 36 hours with a CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥ 75 years, Diabetes, Stroke or transient ischemic attack, Vascular disease, Age 65-74 years, Sex category) score of 3?
What precautions are needed for calcium supplementation in a 65-year-old patient with vitamin D deficiency and potential kidney disease?
Is osmophobia (abnormal sensitivity to smells) a specific feature of migraine?
How is raised intracranial pressure (ICP) with dehydration managed in a 1-year-old child?
What are the diagnosis, symptoms, and treatment options for organophosphorus (OP) poisoning in a patient with potential pre-existing medical conditions, such as respiratory or cardiac disease, and varying demographics, including age and occupation?
How to treat a patient with severe hypercalcemia?
What is the appropriate dosage of Piptax?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.